580 suspected cases of Chikungunya reported – CMO

Chief Medical Officer, Dr. Shamdeo PersaudGeorgetown: Chief Medical Officer, Dr Shamdeo Persaud has confirmed that Guyana has recorded a total of 76 cases of the Chikungunya disease from approximately 250 samples that were sent to the Caribbean Public Health Agency (CARPHA) in Trinidad and Tobago.

The disease is not associated with high fatality, as overall, there have been only three Chikungunya-related deaths recorded in the Caribbean.

The CMO said that based on reports coming from health facilities across the country, there are 580 suspected cases. However, there may be milder forms of the disease in some areas. Some of the samples sent to CARPHA are still to be tested (the laboratory conducts testing for other Caribbean countries as well).

The situation in Guyana in terms of the disease is not much different from Caricom jurisdictions. There are currently 921 confirmed cases in the entire Region; however, in some countries the number of cases is not as high as others.

While the prevalence of Chikungunya has been more pronounced in Regions Six and Five and to some extent Four, there have been three reported cases in Region 10, but are associated with travelling, not active transmission.

Chikungunya is a mosquito-borne viral disease; transmitted by the Aedes Aegypti mosquito, which is also known to spread viruses such as dengue, and yellow fever.

Dr Persaud explained that the Aedes Aegypti mosquito is commonly found in many homes. Water collected in containers, old tyres and other vessels provides the perfect breeding ground for these mosquitoes.

Precautionary measures

The CMO said that even though fogging and more general environmental controls are necessary, a lot more precautionary measures can and should be taken at the household level.

“We feel that a lot can be done at the household level… from the inspections carried out, we have noted that there are several common breeding grounds around the homes where even fogging would not impact effectively,” he said.

The CMO also called for greater community involvement and understanding of the virus and how it can be prevented.

Vector control personnel in Georgetown have been going around in communities where Chikungunya and dengue have been identified to conduct yard inspections and distributing “abate”.

This larvicide is placed in water to prevent the growth of larvae and ultimately the multiplication of mosquitoes.

However, there have been reports of cases where people throw out the treated water before the larvicidal agent would have had enough time to work and kill the larvae before they develop into adult mosquitoes.

The Health Ministry is urging residents to keep their surroundings clean to prevent them from becoming breeding grounds for mosquitoes. Wearing protective clothing and using repellents and mosquito nets are also effective measures.

Fogging

At present, fogging cycles are ongoing in parts of Regions Six, Five and Four. These exercises are still to commence in Regions Three and 10 as a result of a number of factors including the weather and availability of adequate personnel.

Dr Persaud explained that the same Vector Control Unit that is in charge of the fogging exercise is also tasked with the management of malaria, another mosquito-borne disease, in Guyana, and this unit is very stretched at this point in time.

The CMO explained that while fogging has been deemed helpful, it comes with environmental and other health-risk consequences.

“Our programme usually recommends two cycles of fogging annually per populated areas like Georgetown and the East Bank.

Too much of fogging could lead to additional risk due to chemical exposure… it is an intermittent intervention to help to reduce the mosquitoes, but more measures should be taken in the home,” the CMO said.

Chikungunya is a viral infection that is self-limiting. This means that after the usual bout of fever, the body’s immune system would take care of the viral infection.

However, in rare cases, especially where people have had predisposing joint conditions such as arthritis, the pain may persist.

“Once you have contracted it, you have life-long protection against; it is one of those viral diseases that you develop immunity against,” the CMO said.

Treatment

At present, there are no specific antibiotic or antiviral medicines that can be used to treat Chikungunya. The disease is treated symptomatically; whereby persons experiencing high fevers are prescribed fever and pain medication.

A suspected Chikungunya case is identified when a person has a temperature of over 38.5 degrees Celsius and is also experiencing severe arthritis (joint pains).

It also helps to know whether the person experiencing these symptoms hail from an area where the disease has been prevalent.